Chest
CommentaryUse It or Lose It: Medicare's New Paradigm for Durable Medical Equipment Coverage?
Section snippets
Acknowledgments
Financial/nonfinancial disclosures: The author has reported to CHEST the following conflicts of interest: Within the last 3 years, Dr Brown served on the boards of directors of the American Academy of Sleep Medicine, Associated Professional Sleep Societies LLC, American Board of Sleep Medicine, and American Sleep Medicine Foundation, and served on the Health Policy Committee of the American Thoracic Society. He chairs the Polysomnography Practice Advisory Committee of the New Mexico Medical
References (39)
- et al.
The new local coverage determination criteria for adherence to positive airway pressure treatment: testing the limits?
Chest
(2010) - et al.
Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome
Lancet
(1994) - et al.
Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure
Chest
(2005) - et al.
Long-term effect of continuous positive airway pressure on BP in patients with hypertension and sleep apnea
Chest
(2007) - et al.
Adherence to sleep apnea therapy and use of lipid-lowering drugs: a study of the healthy-user effect
Chest
(2010) - et al.
Predictors of compliance with antihypertensive therapy in a high-risk medicaid population
J Natl Med Assoc
(2009) - et al.
Predictors of medication adherence using a multidimensional adherence model in patients with heart failure
J Card Fail
(2008) - et al.
Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study
Clin Ther
(2009) - et al.
Racial differences in medication adherence: A cross-sectional study of medicare enrollees
Am J Geriatr Pharmacother
(2010) - et al.
Group education sessions and compliance with nasal CPAP therapy
Chest
(1997)
Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study
Chest
Medicare National Coverage Determinations Manual. Chapter 1, part 4 (Sections 200-310.1) Coverage Determinations
LCD for positive airway pressure (PAP) devices for the treatment of obstructive sleep apnea (L11518)
A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea
Am J Respir Crit Care Med
Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning
Sleep
Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence
BMJ
Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome
Thorax
Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome
Am J Respir Crit Care Med
Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy
Am J Respir Crit Care Med
Cited by (10)
Treatment of Obstructive Sleep Apnea: Achieving Adherence to Positive Airway Pressure Treatment and Dealing with Complications
2020, Sleep Medicine ClinicsCitation Excerpt :The purpose of this review is to define PAP adherence, identify and discuss current challenges faced by clinicians as they provide PAP therapy to their patients, and provide an overview of the various strategies to increase PAP use, with an emphasis on understanding, recognizing, and overcoming common barriers to care and using high-yield interventions early in the treatment course. Currently accepted insurance criteria in the United States contend that “adherent” equates to the use of PAP greater than 4 hours per night for at least 70% of nights.15,18 Therefore, an individual only has to use PAP 86 hours per month, or 35% of the total recommended sleep time, to be considered adherent.
Treatment of Obstructive Sleep Apnea: Achieving Adherence to Positive Airway Pressure Treatment and Dealing with Complications
2017, Sleep Medicine ClinicsCitation Excerpt :The purpose of this review is to define PAP adherence, identify and discuss current challenges faced by clinicians as they provide PAP therapy to their patients, and provide an overview of the various strategies to increase PAP use, with an emphasis on understanding, recognizing, and overcoming common barriers to care and using high-yield interventions early in the treatment course. Currently accepted insurance criteria in the United States contend that “adherent” equates to the use of PAP greater than 4 hours per night for at least 70% of nights.15,18 Therefore, an individual only has to use PAP 86 hours per month, or 35% of the total recommended sleep time, to be considered adherent.
Maximizing positive airway pressure adherence in adults: A common-sense approach
2013, ChestCitation Excerpt :Although the question of how much PAP therapy is enough remains unanswered, in 2009, the Centers for Medicare & Medicaid Services adopted a requirement of 4 h of PAP use on 70% of nights, or 21 days in a consecutive 30-day period, to continue medical coverage for PAP therapy. This cutoff has been criticized as too lenient for accepting a suboptimal level of use, as well as too stringent as some patients with OSA benefit from <4 h use.7,8 A number of investigations have evaluated how much PAP use is needed to ensure maximal benefit from the therapy.
International Consensus Statement on Obstructive Sleep Apnea
2023, International Forum of Allergy and RhinologyNeighborhoods with greater prevalence of minority residents have lower continuous positive airway pressure adherence
2021, American Journal of Respiratory and Critical Care Medicine
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (http://www.chestpubs.org/site/misc/reprints.xhtml).